Lv4
569 积分 2021-05-16 加入
多巴胺受体激动剂在帕金森模型中的神经保护机制研究
1天前
待确认
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report
2天前
求助中
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
2天前
已完结
Current and novel infusion therapies for patients with Parkinson's disease
2天前
已完结
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa
2天前
已完结
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations
2天前
已完结
MOONRAY-01, a phase 1 study of LY3962673, a potent, orally bioavailable, and selective KRAS G12D inhibitor in KRAS G12D -mutant solid tumors
3天前
已完结
Parkinson disease therapy: current strategies and future research priorities
9天前
已完结
Advance in pharmaceutical preparations of the dopamine receptor agonist rotigotine for the treatment of Parkinson's disease
16天前
已完结
Population pharmacokinetics of rotigotine extended‐release microspheres for intramuscular injection in patients with early‐stage Parkinson's disease
16天前
已完结
皖公网安备34019202002308
